Skip to main content
. 2022 Aug 26;13:911801. doi: 10.3389/fgene.2022.911801

FIGURE 5.

FIGURE 5

Potential implications of SFTA2 expression in outcomes of NSCLC. (A) We compared the expression of SFTA2 in normal and tumor tissues in NSCLC and subgroups of LUAD and LUSC. (B) We performed univariate and multivariate regression analyses to find the factors related to the survival of NSCLC patients. (C) We utilized independent cohort samples to study the relationship between SFTA2 expression and survival prognosis.